The TenderGuard™ product portfolio consists of remarkably soft, comfortable, and protective fabrics. TenderGuard™ BioBased and BioFilter fabrics are designed for civil use and source control for infectious disease.
Hologenix, creators of Celliant®, infrared responsive technology, and Kelheim Fibres, the world-leading manufacturer of viscose specialty fibers, have partnered to launch Celliant Viscose at ISPO Munich 2021.
The University of Maine Forest Bioproducts Research Institute (FBRI) will upgrade its Technology Research Center (TRC) in Old Town and Process Development Center (PDC) in Jenness Hall to bolster ongoing efforts to create new bioproducts, increase production and find uses for woody biomass materials typically considered waste.
Swedish road and infrastructure operator Svevia has decided to collaborate with Stora Enso in testing lignin in asphalt. Through this collaboration, Svevia aims to replace part of the oil-based binder with nature’s own binder – lignin, Lineo ™ by Stora Enso. The lignin containing asphalt is currently being tested out on Swedish roads.
Elkem has decided to invest in a new biocarbon pilot plant in Canada. The project aims to secure industrial verification of Elkem’s technology for renewable biocarbon, with a long-term goal of contributing to climate-neutral metal production. The technology also has potential for application in other industry sectors, contributing to reduced CO2 emissions.
Wood chips, it must be admitted, are not the most glamorous material around. Scattered in gardens or lining the cages of household pets, it is a commodity that attracts little attention. Luckily, a team of researchers in McGill’s Department of Chemistry developed a method to create carboxylated crystalline nano-cellulose using this often-ignored by-product of the pulp and paper industry.
(UPM, Helsinki, 20.8.2020 at 10:00 EET) FibDex® wound dressing – made from nanofibrillar cellulose by UPM Biomedicals – has taken a significant step in its path to market, as leading medical device distributor Steripolar Oy now sells the product in Finland. FibDex is the first clinical product of renowned forest-based bioindustry company UPM and shows promising signs for future developments, such as cell therapy.